Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 2:32 a.m.

    🔍 Meisner Derek M (Executive)

    Company: Acumen Pharmaceuticals, Inc. (ABOS)

    Report Date: 2026-01-05

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 26,668

    Detailed Transactions and Holdings:

    • Sold 4,000 shares of Common Stock at $1.9595 per share (Direct)
      Date: 2026-01-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 157,127.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,097 shares of Common Stock at $1.9672 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 150,030.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,801 shares of Common Stock at $1.967 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 146,229.00 | transaction_form_type: 4 | Footnotes: F4, F3
    • Sold 1,700 shares of Common Stock at $1.9876 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 144,529.00 | transaction_form_type: 4 | Footnotes: F5, F6
    • Sold 10,070 shares of Common Stock at $1.9896 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 134,459.00 | transaction_form_type: 4 | Footnotes: F4, F7

    Footnotes:

    • F1: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 15, 2024.
    • F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9200 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F3: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $2.0000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F4: Represents the number of shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
    • F5: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 29, 2025.
    • F6: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0200. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F7: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0250. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Search

News categories